Abstract
The role of human bone morphogenetic protein-infused in combination with traditional Chinese medicine Carthamus tinctorius in repairing oral bone defects (OBD) was evaluated in this work. An experiment was conducted on a rat OBD model, where rats were randomly rolled into Groups A, B, and C based on their different treatments. Micro-CT was utilized to measure jaw bone volume fraction (BV/TV) and bone mineral density (BMD) in rats, while a biomechanical testing machine assessed compressive strength of the jaw bone. Cell culture technique was employed to measure the osteoblast proliferation rate (PR), and enzyme-linked immunosorbent assay was utilized to detect levels of alkaline phosphatase (ALP), osteocalcin (OCN), tumour necrosis factor-alpha (TNF-α), and interleukin (IL)-6 in the serum. Rats in Groups B and C showed higher jaw bone BV/TV, BMD, compressive strength, osteoblast PR, ALP, and OCN, demonstrating no great differences with Group A (P > .05). TNF-α and IL-6 in Groups B and C were lower in comparison with those in Group A (P > .05). Notably, Groups B and C exhibited statistically obvious differences in jaw bone BV/TV, BMD, osteoblast PR, ALP, OCN, TNF-α, and IL-6 levels (P > .05). The combined application of human bone morphogenetic protein-infused and traditional Chinese medicine C. tinctorius demonstrated positive effects on repair of OBD, reducing inflammatory response and promoting bone tissue repair and formation, thus effectively treating OBD.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call